Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
30 07 2019
Historique:
received: 20 10 2018
accepted: 11 07 2019
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 19 12 2019
Statut: epublish

Résumé

Species' differences in cellular factors limit avian influenza A virus (IAV) zoonoses and human pandemics. The IAV polymerase, vPol, harbors evolutionary sites to overcome restriction and determines virulence. Here, we establish host ANP32A as a critical driver of selection, and identify host-specific ANP32A splicing landscapes that predict viral evolution. We find that avian species differentially express three ANP32A isoforms diverging in a vPol-promoting insert. ANP32As with shorter inserts interact poorly with vPol, are compromised in supporting avian-like IAV replication, and drive selection of mammalian-adaptive vPol sequences with distinct kinetics. By integrating selection data with multi-species ANP32A splice variant profiling, we develop a mathematical model to predict avian species potentially driving (swallow, magpie) or maintaining (goose, swan) mammalian-adaptive vPol signatures. Supporting these predictions, surveillance data confirm enrichment of several mammalian-adaptive vPol substitutions in magpie IAVs. Profiling host ANP32A splicing could enhance surveillance and eradication efforts against IAVs with pandemic potential.

Identifiants

pubmed: 31363119
doi: 10.1038/s41467-019-11388-2
pii: 10.1038/s41467-019-11388-2
pmc: PMC6667478
doi:

Substances chimiques

ANP32A protein, human 0
Nuclear Proteins 0
PB2 protein, influenza virus 0
RNA-Binding Proteins 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3396

Références

Elife. 2019 Jun 04;8:
pubmed: 31159925
Cell Host Microbe. 2015 Mar 11;17(3):309-319
pubmed: 25704008
Virology. 2011 Mar 30;412(1):9-18
pubmed: 21251691
Elife. 2015 Oct 29;4:
pubmed: 26512887
Virology. 1998 Sep 1;248(2):295-304
pubmed: 9721238
Cell Rep. 2015 Nov 17;13(7):1467-1480
pubmed: 26549460
Emerg Infect Dis. 2014 May;20(5):850-3
pubmed: 24751370
Cell Rep. 2018 Sep 4;24(10):2581-2588.e4
pubmed: 30184493
Lancet. 2017 Aug 12;390(10095):697-708
pubmed: 28302313
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21312-6
pubmed: 19995968
Curr Top Microbiol Immunol. 2014;385:359-75
pubmed: 24990620
J Virol. 2006 Aug;80(15):7590-9
pubmed: 16840338
J Virol. 1999 Nov;73(11):9679-82
pubmed: 10516084
J Virol. 2014 Nov;88(22):13436-46
pubmed: 25210184
Nat Commun. 2011 Jan 18;2:156
pubmed: 21245837
PLoS One. 2012;7(5):e36415
pubmed: 22570712
Virology. 1998 Sep 1;248(2):305-11
pubmed: 9721239
Elife. 2019 Apr 30;8:
pubmed: 31038123
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650
pubmed: 30958812
J Virol. 2006 Jun;80(12):5976-83
pubmed: 16731936
Nat Rev Microbiol. 2019 Jan;17(2):67-81
pubmed: 30487536
PLoS Pathog. 2009 Jan;5(1):e1000252
pubmed: 19119420
J Virol. 2016 Jun 10;90(13):5928-5938
pubmed: 27076644
Cell Rep. 2017 Sep 12;20(11):2538-2546
pubmed: 28903035
J Virol. 2013 Oct;87(19):10884-8
pubmed: 23864613
Nature. 1977 Dec 15;270(5638):617-8
pubmed: 593388
J Virol. 2013 Jul;87(13):7200-9
pubmed: 23616660
PLoS Pathog. 2016 Apr 20;12(4):e1005583
pubmed: 27097026
Nature. 2016 Jan 7;529(7584):101-4
pubmed: 26738596
Nat Rev Microbiol. 2016 Aug;14(8):479-93
pubmed: 27396566
J Virol. 1993 Apr;67(4):1761-4
pubmed: 8445709
J Virol. 2017 Oct 13;91(21):
pubmed: 28814525
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
mBio. 2011 Aug 16;2(4):
pubmed: 21846828
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
J Virol. 2019 Jun 14;93(13):
pubmed: 30996088
Emerg Microbes Infect. 2019;8(1):262-271
pubmed: 30866780
Influenza Other Respir Viruses. 2012 Nov;6(6):404-16
pubmed: 22260278
J Virol. 2009 Dec;83(24):13015-8
pubmed: 19793811
mBio. 2017 Jun 13;8(3):
pubmed: 28611246

Auteurs

Patricia Domingues (P)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.

Davide Eletto (D)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.

Carsten Magnus (C)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.
Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058, Basel, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland.

Hannah L Turkington (HL)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.

Stefan Schmutz (S)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.

Osvaldo Zagordi (O)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.

Matthias Lenk (M)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, 17493, Greifswald-Insel Riems, Germany.

Martin Beer (M)

Institute of Diagnostic Virology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, 17493, Greifswald-Insel Riems, Germany.

Silke Stertz (S)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.

Benjamin G Hale (BG)

Institute of Medical Virology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland. hale.ben@virology.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH